These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7906979)

  • 1. [Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].
    Untch M; Sevin BU; Untch A; Konecny G; Nestle-Krämling C; Korell M; Hepp H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():311-3. PubMed ID: 7906979
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
    Untch M; Untch A; Sevin BU; Angioli R; Perras JP; Koechli O; Averette HE
    Anticancer Drugs; 1994 Feb; 5(1):24-30. PubMed ID: 7910494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay.
    Untch M; Sevin BU
    Contrib Gynecol Obstet; 1994; 19():145-55. PubMed ID: 7995046
    [No Abstract]   [Full Text] [Related]  

  • 4. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
    Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the adenosine triphosphate chemosensitivity assay for pre-therapeutic determination of the chemosensitivity of breast cancer cells in cell culture].
    Köchli OR; Sevin BU; Schär G; Haller U
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):7-16. PubMed ID: 7705600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of data on gynecologic cancer cell lines: potential applications of ATP-cell viability assays.
    Nguyen HN; Sevin BU; Perras JP; Averette HE
    Contrib Gynecol Obstet; 1994; 19():132-44. PubMed ID: 7995045
    [No Abstract]   [Full Text] [Related]  

  • 7. ATP-cell viability assay methodology in both fresh gynecologic tumors and cell lines.
    Köchli OR; Perras JP; Sevin BU
    Contrib Gynecol Obstet; 1994; 19():108-21. PubMed ID: 7995042
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms.
    Koechli OR; Schaer GN; Sevin BU; Perras JP; Schenk V; Rodriguez M; Untch M; Steren A; Haller U
    Anticancer Drugs; 1995 Feb; 6(1):94-100. PubMed ID: 7756689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer.
    Sevin BU; Perras JP
    Am J Obstet Gynecol; 1997 Apr; 176(4):759-66; discussion 766-8. PubMed ID: 9125599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological activity of novel C2-C3' N-Linked macrocyclic taxoids.
    Ojima I; Geng X; Lin S; Pera P; Bernacki RJ
    Bioorg Med Chem Lett; 2002 Feb; 12(3):349-52. PubMed ID: 11814794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
    Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New highly active taxoids from 9 beta-dihydrobaccatin-9,10-acetals.
    Ishiyama T; Iimura S; Ohsuki S; Uoto K; Terasawa H; Soga T
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1083-6. PubMed ID: 11909723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
    Liu S; Qian X; Peng Z; Wang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W; Gu M; Liang L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemosensitivity test of breast cancer].
    Oura S; Tanino H; Naito Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():581-6. PubMed ID: 11026054
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of docetaxel/paclitaxel with irradiation in ovarian carcinoma cell lines in bidimensional (sulforhodamine B assay) and tridimensional (spheroids) cultures.
    Griffon-Etienne G; Merlin JL; Marchal C
    Anticancer Drugs; 1996 Aug; 7(6):660-70. PubMed ID: 8913435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of paclitaxel-2'-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug.
    Pendri A; Conover CD; Greenwald RB
    Anticancer Drug Des; 1998 Jul; 13(5):387-95. PubMed ID: 9702205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
    Nogaki M; Ichihashi H
    Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New highly active taxoids from 9beta-dihydrobaccatin-9,10-acetals. Part 3.
    Takeda Y; Yoshino T; Uoto K; Chiba J; Ishiyama T; Iwahana M; Jimbo T; Tanaka N; Terasawa H; Soga T
    Bioorg Med Chem Lett; 2003 Jan; 13(2):185-90. PubMed ID: 12482420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer cell lines are sensitive to paclitaxel.
    Rantanen V; Grénman S; Kulmala J; Grénman R
    Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.